Get started
Author

Ed Uchio

Observed name: Ed M. Uchio
Observed institution: University of California, Irvine
OpenAlex ID: A5046513914
955 CORE1: phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
2021 · Roger Li, Gary Steinberg, et al. · 8
PDF
426 A phase 3, single-arm study of CG0070 in subjects with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
2021 · Ed Uchio, Donald Lamm, et al. · Regular and Young Investigator Award Abstracts · 2
PDF
Abstract CT036: CORE1: Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
2022 · Roger Li, Gary Steinberg, et al. · Cancer Research · 1
Abstract CT233: A phase 3, single-arm study of CG0070 in subjects with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
2022 · Ed Uchio, Donald Lamm, et al. · Cancer Research
Mp54-03 Core1: Phase 2, Single Arm Study of Cg0070 Combined With Pembrolizumab in Patients With Non Muscle Invasive Bladder Cancer (nmibc) Unresponsive to Bacillus Calmette-guerin (bcg)
2022 · Roger Li, Gary Steinberg, et al. · The Journal of Urology
Works count: 5
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type